Morphological spectrum of light chain deposition disease of the kidney in 45 patients. Experience in a multiple myeloma center

被引：0
|
作者：
Gokden, N [1 ]
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1234
引用
收藏
页码：267A / 267A
页数：1
相关论文
共 50 条
  • [41] DEPURATION OF LIGHT CHAINS IN THE MYELOMA KIDNEY. EXPERIENCE FROM A CENTER
    Senin Magan, A.
    Vallejo Luna, K.
    Ramos Terrades, N.
    Dieli Crimi, R.
    Bosch Albarada, F.
    Gironella Mesa, M.
    HAEMATOLOGICA, 2018, 103 : 88 - 89
  • [42] Nonsecretory and Light Chain Escape in Patients With Multiple Myeloma
    Patel, Urmeel H.
    Drabick, Joseph J.
    Malysz, Jozef
    Talamo, Giampaolo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (12) : E515 - E519
  • [43] Light chain deposition disease with low glomerular proteinuria and multiple myeloma: If you search you find
    Gobbi, Laura
    Naso, Elena
    Dal Santo, Luca
    Fedrigo, Marny
    Del Prete, Dorella
    Angelini, Annalisa
    Vertolli, Ugo
    Calo, Lorenzo A.
    NEPHROLOGY, 2021, 26 (10) : 842 - 843
  • [44] Sensitivity of serum free light chain measurement of residual disease in multiple myeloma patients
    Mead, Graham Peter
    Drayson, Mark Trehane
    BLOOD, 2009, 114 (08) : 1717 - 1717
  • [45] LIGHT CHAIN REMOVAL IN MULTIPLE MYELOMA PATIENTS WITH HFR-SUPRA HEMODIALYSIS: OUR EXPERIENCE
    Pol Heres, Salia V.
    Moyano Franco, Maria Jesus
    Alonso Garcia, Fabiola
    Jimenez Vibora, Elena
    Salguiera Lazo, Andmercedes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I704 - I705
  • [46] A Unique Presentation of Light Chain Deposition Disease: Kidney Disease With No Proteinuria
    Debnath, Dipanjan
    Zhuang, Eric
    Hassan, Abdulahi
    Pizzi, Erica
    Mehdi, Ali
    Esan, Olukemi
    Raza, Shahzad
    Mewawalla, Prerna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S205 - S206
  • [47] Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
    Zhang Xin
    Yu Xiaojuan
    Wang Suxia
    Dong Yujun
    Zhao Minghui
    Zhou Fude
    中华医学杂志英文版, 2025, 138 (02)
  • [48] Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
    Zhang, Xin
    Yu, Xiaojuan
    Wang, Suxia
    Dong, Yujun
    Zhao, Minghui
    Zhou, Fude
    CHINESE MEDICAL JOURNAL, 2025, 138 (02) : 246 - 248
  • [49] SYSTEMIC LIGHT CHAIN DISEASE COMPLICATING MULTIPLE-MYELOMA
    GRUSSENDORF, M
    GRUSSENDORF, M
    WALDHERR, R
    SEELIG, HP
    RITZ, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (37) : 1405 - 1409
  • [50] Light Chain Deposition Disease (LCDD) in the Setting of Smoldering Myeloma (SM)
    Adewuyi, Joel O.
    Shah, Chintan V.
    Modi, Dhruv K.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 589 - 589
12345